Clinical Trials List
Protocol Numbertau201903
2019-08-01 - 2022-07-31
Phase II
Recruiting2
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/20
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Principal Investigator
Co-Principal Investigator
- Shih-Hsin Chen Division of Nuclear Medicine
- Kun-Ju Lin Division of Nuclear Medicine
- Tsung-Ying Ho Division of Nuclear Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
80 participants
-
Global
80 participants
